Biodesix Inc balance sheet

At the end of fiscal 2025, Biodesix Inc had total assets of $87.5m, total liabilities of $89.9m and shareholders' equity of −$2.5m. It held $19.0m in cash against $50.0m of debt: net debt of $31.0m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Biodesix Inc: balance sheet, annual
Fiscal year	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Cash and equivalents	5	62	33	43	26	26	19	30
Receivables	5	15	4	5	8	9	9	9
Total current assets	13	86	44	53	40	39	33	44
Goodwill	15	15	15	15	15	15	15	15
Total assets	45	121	76	93	99	97	87	95
Accounts payable	2	9	2	2	3	2	3	2
Deferred revenue (current)	1	4	2	1	0	1	1	0
Total current liabilities	23	32	29	23	33	14	17	15
Long-term debt	24	28	10	30	40	40	50	50
Total debt	49	40	10	30	40	40	50	50
Total liabilities	76	80	56	72	95	76	90	86
Shareholders' equity	−225	41	20	21	5	21	−2	9
Non-controlling interests and other (assets − liabilities − equity)	194	—	—	—	—	—	—	—
Net debt (negative = net cash)	44	−22	−23	−13	14	14	31	20
Shares outstanding	—	—	—	—	—	7m	8m	11m

US$ millions unless shown otherwise. Fiscal quarters.

Biodesix Inc: balance sheet, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Receivables	8	9	8	7	13	9	10	9
Total current assets	44	39	30	32	33	33	41	44
Goodwill	15	15	15	15	15	15	15	15
Total assets	103	97	86	88	89	87	95	95
Accounts payable	3	2	3	3	4	3	4	2
Deferred revenue (current)	1	1	1	1	3	1	0	0
Total current liabilities	13	14	13	15	18	17	14	15
Long-term debt	40	40	40	50	50	50	50	50
Total debt	40	40	40	50	50	50	50	50
Total liabilities	75	76	75	87	90	90	86	86
Shareholders' equity	28	21	11	1	−2	−2	9	9
Shares outstanding	145m	7m	146m	147m	8m	8m	10m	11m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: BDSX vs MDXH BDSX vs HBIO BDSX vs CDXS

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Biodesix Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Biodesix Inc.